Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Andrew

Showing results (351-360 of 369) with videos related to

Pageof 37
Sort By:
Vaccine|March 22, 2022
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assayJason J LeBlanc, May ElSherif, Lingyun Ye, et al.
The Journal of Infectious Diseases|August 12, 2025
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
Vaccine|September 11, 2023
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2018
The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in CanadaM K Nichols, M K Andrew, L Ye, et al.
Open Forum Infectious Diseases|February 19, 2025
Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research NetworkHenrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
The Journal of Infectious Diseases|September 22, 2017
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly PeopleMelissa K Andrew, Vivek Shinde, Lingyun Ye, et al.
Open Forum Infectious Diseases|April 3, 2026
Clinical Characteristics and Severity of Rhinovirus/Enterovirus-Associated Hospitalizations: A Multicountry Analysis From the Global Influenza Hospital Surveillance Network, 2017-2024Angelica M Revilla, Sonia M Raboni, Heloisa I G Giamberardino, et al.
BMC Infectious Diseases|December 30, 2017
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in CanadaMelissa K Andrew, Vivek Shinde, Todd Hatchette, et al.
Influenza and Other Respiratory Viruses|March 6, 2025
Severity Scale of Influenza and Acute Respiratory Illness Hospitalizations to Support Viral Genomic Surveillance: A Global Influenza Hospital Surveillance Network Pilot StudyBronke Boudewijns, Saverio Caini, Marco Del Riccio, et al.
Influenza and Other Respiratory Viruses|February 26, 2019
Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders NetworkSuleiman Abusrewil, Abdulrahman Algeer, Alanoud Aljifri, et al.
Pageof 37

Showing results (351-360 of 369) with videos related to

Sort By:
Pageof 37
Vaccine|March 22, 2022
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assayJason J LeBlanc, May ElSherif, Lingyun Ye, et al.
The Journal of Infectious Diseases|August 12, 2025
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
Vaccine|September 11, 2023
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2018
The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in CanadaM K Nichols, M K Andrew, L Ye, et al.
Open Forum Infectious Diseases|February 19, 2025
Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research NetworkHenrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
The Journal of Infectious Diseases|September 22, 2017
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly PeopleMelissa K Andrew, Vivek Shinde, Lingyun Ye, et al.
Open Forum Infectious Diseases|April 3, 2026
Clinical Characteristics and Severity of Rhinovirus/Enterovirus-Associated Hospitalizations: A Multicountry Analysis From the Global Influenza Hospital Surveillance Network, 2017-2024Angelica M Revilla, Sonia M Raboni, Heloisa I G Giamberardino, et al.
BMC Infectious Diseases|December 30, 2017
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in CanadaMelissa K Andrew, Vivek Shinde, Todd Hatchette, et al.
Influenza and Other Respiratory Viruses|March 6, 2025
Severity Scale of Influenza and Acute Respiratory Illness Hospitalizations to Support Viral Genomic Surveillance: A Global Influenza Hospital Surveillance Network Pilot StudyBronke Boudewijns, Saverio Caini, Marco Del Riccio, et al.
Influenza and Other Respiratory Viruses|February 26, 2019
Influenza surveillance in Middle East, North, East and South Africa: Report of the 8th MENA Influenza Stakeholders NetworkSuleiman Abusrewil, Abdulrahman Algeer, Alanoud Aljifri, et al.
Pageof 37